Foundation Medicine has reported on that. Of the 79,000 cancer patients FMI tested in 2017, 38% percent were matched with an FDA approved therapy, 83% percent were matched with at least one relevant clinical trial, and all of them had at least one of those two outcomes.
KEEP UP WITH WHAT’S HAPPENING
JOIN THE MOVEMENT - STAY IN TOUCH
Sign up for email updates and news from SequenceMe.